| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.BCP.2005.02.004 |
| P8608 | Fatcat ID | release_iynbrupwkvd4vkykbwqmg6uvau |
| P698 | PubMed publication ID | 15857604 |
| P5875 | ResearchGate publication ID | 7879706 |
| P2093 | author name string | Karl Walter Bock | |
| Christoph Köhle | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Tumor promotion | Q7852681 |
| apoptotic process | Q14599311 | ||
| P304 | page(s) | 1403-1408 | |
| P577 | publication date | 2005-05-01 | |
| P1433 | published in | Biochemical Pharmacology | Q864229 |
| P1476 | title | Ah receptor- and TCDD-mediated liver tumor promotion: clonal selection and expansion of cells evading growth arrest and apoptosis | |
| P478 | volume | 69 |
| Q47375196 | A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells. |
| Q46316992 | Actein alleviates 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated cellular dysfunction in osteoblastic MC3T3-E1 cells. |
| Q37303870 | Activation of the aryl hydrocarbon receptor during different critical windows in pregnancy alters mammary epithelial cell proliferation and differentiation |
| Q33509195 | Analysis and modeling of time-course gene-expression profiles from nanomaterial-exposed primary human epidermal keratinocytes |
| Q35458027 | Aryl hydrocarbon receptor ligands in cancer: friend and foe. |
| Q64072211 | Computational prediction and in vitro validation of VEGFR1 as a novel protein target for 2,3,7,8-tetrachlorodibenzo-p-dioxin |
| Q34994927 | Cross-species transcriptomic analysis elucidates constitutive aryl hydrocarbon receptor activity |
| Q46960448 | Differential expression profiling of the hepatic proteome in a rat model of dioxin resistance: correlation with genomic and transcriptomic analyses. |
| Q42726093 | Effect of aflatoxin B1 on nuclear receptors PXR, CAR, and AhR and their target cytochromes P450 mRNA expression in primary cultures of human hepatocytes. |
| Q26747621 | Environmental Ligands of the Aryl Hydrocarbon Receptor and Their Effects in Models of Adult Liver Progenitor Cells |
| Q36593646 | Evidence supporting the hypothesis that one of the main functions of the aryl hydrocarbon receptor is mediation of cell stress responses |
| Q27490242 | Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma |
| Q28383182 | Gene-chemical interactions in the developing mammalian nervous system: Effects on proliferation, neurogenesis and differentiation |
| Q37399410 | Hepatitis C virus drives the pathogenesis of hepatocellular carcinoma: from immune evasion to carcinogenesis. |
| Q39037022 | Hepatotoxic effects of cyproconazole and prochloraz in wild-type and hCAR/hPXR mice |
| Q42472044 | Immunohistochemical analyses at the late stage of tumor promotion by oxfendazole in a rat hepatocarcinogenesis model |
| Q36940631 | Inflammatory signaling and aryl hydrocarbon receptor mediate synergistic induction of interleukin 6 in MCF-7 cells |
| Q112623136 | KnowTox: pipeline and case study for confident prediction of potential toxic effects of compounds in early phases of development |
| Q38020789 | Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes--conclusions from the 3rd International ESTP Expert Workshop |
| Q36068139 | Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass? |
| Q33596822 | Methylation of dietary flavones increases their metabolic stability and chemopreventive effects |
| Q38163594 | Mode of action and dose-response framework analysis for receptor-mediated toxicity: The aryl hydrocarbon receptor as a case study. |
| Q36466007 | Modeling drug- and chemical-induced hepatotoxicity with systems biology approaches. |
| Q46038783 | Molecular expression analysis of beta-naphthoflavone-induced hepatocellular tumors in rats. |
| Q92310282 | PROTACs: great opportunities for academia and industry |
| Q91793212 | Phase 0 of the Xenobiotic Response: Nuclear Receptors and Other Transcription Factors as a First Step in Protection from Xenobiotics |
| Q37756178 | Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoids. |
| Q36102843 | Role of the Aryl Hydrocarbon Receptor in Colon Neoplasia |
| Q37108803 | Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target |
| Q39309007 | Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target. |
| Q81475692 | TCDD deregulates contact inhibition in rat liver oval cells via Ah receptor, JunD and cyclin A |
| Q33753495 | TCDD promotes lung tumors via attenuation of apoptosis through activation of the Akt and ERK1/2 signaling pathways. |
| Q39436555 | The Alternaria mycotoxins alternariol and alternariol methyl ether induce cytochrome P450 1A1 and apoptosis in murine hepatoma cells dependent on the aryl hydrocarbon receptor |
| Q50327400 | The Aryl Hydrocarbon Receptor and Tumor Immunity. |
| Q40767295 | The adverse outcome pathway for rodent liver tumor promotion by sustained activation of the aryl hydrocarbon receptor |
| Q37682508 | The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth. |
| Q37279436 | The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways |
| Q37151306 | The environmental carcinogen benzo[a]pyrene induces a Warburg-like metabolic reprogramming dependent on NHE1 and associated with cell survival. |
| Q37090414 | Treatment of mice with the Ah receptor agonist and human carcinogen dioxin results in altered numbers and function of hematopoietic stem cells |
| Q38812637 | Tumour-promoting activity of polycyclic aromatic hydrocarbons and their oxygenated or nitrated derivatives |
Search more.